Search
 
 

Display results as :
 


Rechercher Advanced Search

Check Out Our Sponsors
Brought to you by
Hair Loss Forum
Navigation
 Portal
 Index
 Memberlist
 Profile
 FAQ
 Search
Latest topics
Navigation
 Portal
 Index
 Memberlist
 Profile
 FAQ
 Search

Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?

View previous topic View next topic Go down

Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?

Post  CausticSymmetry on Fri Aug 12, 2016 2:31 am

Arab J Urol. 2016 Feb 23;14(2):157-62. doi: 10.1016/j.aju.2016.01.003. eCollection 2016.
Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
Agamia NF1, Abou Youssif T2, El-Hadidy A3, El-Abd A4.

OBJECTIVE:
To evaluate the incidence of benign prostatic hyperplasia (BPH) and metabolic syndrome in patients with androgenetic alopecia (AGA) in comparison with those with no AGA, as several previous studies have reported inconsistent results of an association between metabolic syndrome and BPH with AGA.
PATIENTS SUBJECTS AND METHODS:
This cross-sectional study included 400 participants, divided into 300 patients diagnosed with AGA, with different grades according to Norwood-Hamilton classification, and 100 control subjects with no AGA. Criteria for diagnosis of metabolic syndrome according to Adult Treatment Panel-III criteria (waist circumference, blood pressure, fasting blood sugar, high-density lipoprotein and triglycerides), as well as criteria for diagnosis of BPH (prostatic volume, urine flow, and prostate-specific antigen) were assessed in all patients and compared with the control subjects.
RESULTS:
There were significant differences between the AGA and no-AGA groups for the following variables: waist circumference, body mass index, fibrinogen level, fasting blood sugar, cholesterol, C-reactive protein, erythrocyte sedimentation rate, and glycosylated haemoglobin. There was a significant difference in number of patients with AGA manifesting criteria of metabolic syndrome (51% vs 28%), as well as BPH diagnostic criteria (36% vs 6.8%) compared with the control subjects. Both BPH and metabolic syndrome were shown to be significant independent variables associated with AGA.
CONCLUSIONS:
Dermatologists, urologists, and primary care physicians should monitor patients with early onset AGA for the development of urinary symptoms, to permit an earlier diagnosis of BPH; and for metabolic syndrome symptoms, to permit early diagnosis of cardiovascular risk factors.
KEYWORDS:
AGA, androgenetic alopecia; Androgenetic alopecia; BMI, body mass index; Benign prostatic hyperplasia; CRP, C-reactive protein; CVD, cardiovascular disease; Cardiovascular risk; DHT, dihydrotestosterone; ESR, erythrocyte sedimentation rate; FBS, fasting blood sugar; HDL, high-density lipoprotein; HbA1c, glycosylated haemoglobin; Metabolic syndrome

_________________
My regimen
http://www.immortalhair.org/mpb-regimen

Now available for consultation (hair and/or health)
http://www.immortalhair.org/health-consultation
avatar
CausticSymmetry
Admin

Posts : 11894
Join date : 2008-07-09

View user profile http://www.immortalhair.org/

Back to top Go down

View previous topic View next topic Back to top

- Similar topics

 
Permissions in this forum:
You cannot reply to topics in this forum